Clinical Trial Update: Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a reduced dose of Menomune in children who previously received meningococcal-conjugate vaccine; completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Meningococcal Disease
• Meningitis
• Meningococcemia

Drugs mentioned

• Menomune (Meningococcal polysaccharide vaccine (serogroups A, C, W, Y))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcemia | Phase 2 | Status: COMPLETED | Results posted: 2009-05-14